𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New insights into therapeutic options for Pompe disease

✍ Scribed by Emmanuel Richard; Gaëlle Douillard-Guilloux; Catherine Caillaud

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
130 KB
Volume
63
Category
Article
ISSN
1521-6543

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Different cellular steps of acid maltase synthesis and subsequent glycogen degradation, by Emmanuel Richard, Gaëlle Douillard–Guilloux, and Catherine Caillaud, pp. 979–986.

📜 SIMILAR VOLUMES

New insights into therapeutic options fo
New insights into therapeutic options for Pompe disease
✍ Emmanuel Richard; Gaëlle Douillard-Guilloux; Catherine Caillaud 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

## Abstract Glycogen storage disease type II or Pompe disease (GSD II, MIM 232300) is a rare inherited metabolic myopathy caused by a deficiency of lysosomal acid α‐glucosidase or acid maltase (GAA; EC 3.2.1.20), resulting in a massive lysosomal glycogen accumulation in cardiac and skeletal muscles

Insights into defibrotide as therapy for
Insights into defibrotide as therapy for veno-occlusive disease
✍ Jennifer R. Gamble; Mathew A. Vadas 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Defibrotide (DF) is a mixture of porcine-derived single-stranded phosphodiester oligonucleotides (9-80-mer; average, 50-mer) that has been successfully used to treat severe hepatic veno-occlusive disease (sVOD) with multiorgan failure (MOF) in patients who have received cytotoxic chemotherapy in pre

Hypouricemic therapy: A novel potential
Hypouricemic therapy: A novel potential therapeutic option for nonalcoholic fatty liver disease
✍ Cheng-Fu Xu; Chao-Hui Yu; Lei Xu; Xiao-Ying Sa; You-Ming Li 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB 👁 1 views

We read with great interest the practice guidelines for the diagnosis and management of autoimmune hepatitis recently issued by the American Association for the Study of Liver Diseases (AASLD). 1 In particular, we appreciate the new definition of biochemical remission, which now requires not only no